Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy

2019 ◽  
pp. 11-18 ◽  
Author(s):  
Cyryl Daroszewski ◽  
Małgorzata Stasiewicz ◽  
Ewa Jaźwińska-Tarnawska ◽  
Anna Rachwalik ◽  
Ewa Mura ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Palliative Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung

QUALITY OF LIFE OF LATE STAGE NON-SMALL CELL LUNG CANCER PATIENTS

2016 ◽  
pp. 85-91
Author(s):  
Phuong Phung
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Late Stage ◽  
Palliative Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
Eortc Qlq

Background: Lung cancer is the most common malignancies and remains the leading cause of cancer-related deaths in Viet Nam. Majority of cases present initially at late stage. Palliative chemotherapy is the standard treatment for these situations to prolong survival and improve quality of life for the patient. Purpose: To appreciate quality of life in patients in late stage non-small cell lung cancer pre-post, during palliative chemotherapy and to determine the factors affecting on post-chemotherapy quality of life. Patients and Methods: A prospective, descriptive study, eligible patients included 65 late stage non-small cell lung cancer patients from Hue University Hospital from 1/2014 to 6/2016. The EORTC QLQ-C30 and Lung cancer Questionnaire EORTC QLQ-LC13 were used to assess quality of life. T-test was used to compare quality of life score at two assessed times. T-test, ANOVA, Mann Whitney, Kruskal Wallis were used to determine the correlation between 2 factors. Pearson and Spearman Coefficient were used to measure the strength of relationship between the factors. Results: The most effected age group was 54.4 ± 11.3. The global health scale before treatment was 47.3± 23.6, the functional scales as well as disease-related symptom scales improved clearly after the 2nd cycle (64.8 ± 16.0) and were relatively stable at the 4th cycle of chemotherapy (62.2 ± 19.3). Meanwhile, the toxicities including hair loss and peripheral neuropathy rose gradually after chemotherapy cycles. Age, occupation, nationality, religion, weight loss, PS, pathology, stage of disease, chemotherapy regimen, progressive disease, disease-related symptoms and treatment-related toxicities associated post-chemotherapy quality of life. Conclusions: This study showed that there were an improvement of quality of life after chemotherapy. Epidemiologic, clinical, treatment factors had effects on post-chemotherapy quality of life. Key words: lung cancer, quality of life, palliative chemotherapy

Association of Depression and Anxiety on Quality of Life, Treatment Adherence, and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

2012 ◽  
Vol 20 (6) ◽  
pp. 1941-1948 ◽  
Author(s):  
Óscar Arrieta ◽  
Laura P. Angulo ◽  
Carolina Núñez-Valencia ◽  
Yuzmiren Dorantes-Gallareta ◽  
Eleazar O. Macedo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Treatment Adherence ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Depression And Anxiety ◽  
Small Cell Lung

Quality Trials and Quality of Life in Non–Small-Cell Lung Cancer

2003 ◽  
Vol 21 (16) ◽  
pp. 3007-3008 ◽  
Author(s):  
Peter Harper ◽  
Tim Plunkett ◽  
David Khayat
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

2009 ◽  
Vol 4 (9) ◽  
pp. 1075-1082 ◽  
Author(s):  
Yingwei Qi ◽  
Steven E. Schild ◽  
Sumithra J. Mandrekar ◽  
Angelina D. Tan ◽  
James E. Krook ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Overall Survival ◽  
Prognostic Factor ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Stage ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document